Biodesix/$BDSX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Biodesix
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Ticker
$BDSX
Sector
Primary listing
Employees
273
Headquarters
Website
Biodesix Metrics
BasicAdvanced
$48M
-
-$5.60
1.00
-
Price and volume
Market cap
$48M
Beta
1
52-week high
$7.85
52-week low
$5.74
Financial strength
Current ratio
2.14
Quick ratio
1.859
Long term debt to equity
6,229.613
Total debt to equity
6,395.343
Interest coverage (TTM)
-4.60%
Profitability
EBITDA (TTM)
-28.076
Gross margin (TTM)
78.77%
Net profit margin (TTM)
-53.66%
Operating margin (TTM)
-44.27%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
-20.81%
Return on equity (TTM)
-219.68%
Valuation
Price to revenue (TTM)
0.595
Price to book
40
Price to tangible book (TTM)
-2.43
Price to free cash flow (TTM)
-1.454
Free cash flow yield (TTM)
-68.78%
Free cash flow per share (TTM)
-4.271
Growth
Revenue change (TTM)
25.70%
Earnings per share change (TTM)
-37.66%
3-year revenue growth (CAGR)
34.80%
3-year earnings per share growth (CAGR)
-46.10%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Biodesix stock?
Biodesix (BDSX) has a market cap of $48M as of September 18, 2025.
What is the P/E ratio for Biodesix stock?
The price to earnings (P/E) ratio for Biodesix (BDSX) stock is 0 as of September 18, 2025.
Does Biodesix stock pay dividends?
No, Biodesix (BDSX) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Biodesix dividend payment date?
Biodesix (BDSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Biodesix?
Biodesix (BDSX) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.